Cannasouth favours prescription of medicinal cannabis by GPs
8th August 2019
Cannasouth has made its submission
to the Ministry of Health (MOH) on the Government’s
proposals for medicinal cannabis regulations to support the
Medicinal Cannabis Scheme.
Cannasouth CEO Mark Lucas says while the company is generally happy with the proposals, it has outlined three key areas of concern in its submission.
“The main issues we see are around requiring specialist approval for patients to access off-label use of non-CBD medicinal products, which will greatly reduce patient access and increase costs.
“Many medicinal cannabis prescriptions will be for general practices and hence should be prescribed by a general practitioner. Requiring a specialist for prescription will likely undermine efforts to provide an effective medicinal cannabis scheme that benefits all parties, from industry to GPs to patients.”
ends
NZ Psychological Society: Remembering The Past Guides Our Future
New Zealand Olympic Committee: Motherhood In Focus For Wāhine Toa Graduates Ahead Of Mother's Day
Early Childhood New Zealand: Budget 2026 Must Protect The Future Of Quality Early Childhood Education
Creative New Zealand: Aotearoa Manu Take World Art Stage As 61st Venice Biennale Opens
Country Music Honours: 2026 Country Music Honours Finalists Announced
Mana Mokopuna: Children’s Commissioner Welcomes New Youth Mental Health And Suicide Prevention Services In Te Tai Tokerau